---
$id: https://graph.org.ai/products/commodity/51172018
$type: Product
source: UNSPSC
code: "51172018"
title: "Piprozolin or piprozoline"
class: "51172000"
classTitle: "Drugs used for gallbladder disease"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Piprozolin or piprozoline

**UNSPSC Code**: 51172018
**Class**: [Drugs used for gallbladder disease](Drugs used for gallbladder disease.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a piperidine with the molecular formula C14H22N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7786W0VV8M, chemically known as ethyl 3-ethyl-4-oxo-5-piperidino-.delta.(sup2, .alpha.)-thiazolidineacetate but generally known as piprozolin, which bears US NIH Compound Identifier 28426. European Medicines Agency schedules Piprozolin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09889MIG. World Health Organization schedules piprozolin in its Anatomical Therapeutic Chemical (ATC) Classification. PIPROZOLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S1C(N2CCCCC2)C(=O)N(C\1=C\C(=O)OCC)CC.

